Related Experiment Video

Updated: Aug 23, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Gene therapy for severe combined immune deficiency

Waseem Qasim1, H Bobby Gaspar, Adrian J Thrasher

  • 1Molecular Immunology Unit, Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK. w.qasim@ich.ucl.ac.uk

Expert Reviews in Molecular Medicine
|July 9, 2004
PubMed

Insights

Gene therapy offers a promising treatment for infants with severe combined immune deficiencies (SCID). This approach corrects genetic defects, providing a viable alternative to traditional stem cell transplants for these vulnerable infants.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Infants with severe combined immune deficiencies (SCID) face life-threatening infections and typically do not survive past one year without intervention.
  • Hematopoietic stem cell transplantation (HSCT) from a matched donor can cure SCID, but suitable donors are often unavailable.
  • Haploidentical HSCT from parental donors is an option but carries higher risks and lower success rates.

Purpose of the Study:

  • To evaluate the efficacy of retroviral gene therapy as an alternative treatment for SCID.
  • To assess the feasibility and outcomes of gene-corrected hematopoietic progenitor cell transplantation.
  • To compare gene therapy outcomes with haploidentical transplantation in SCID patients.

Main Methods:

  • Utilized retroviral gene delivery to correct genetic defects in hematopoietic progenitor cells ex vivo.
  • Transplanted gene-corrected cells into infants with specific SCID types (e.g., SCID-X1, adenosine deaminase deficiency).
  • Monitored immune reconstitution kinetics and clinical outcomes post-transplantation.

Main Results:

  • Gene therapy proved to be a feasible alternative therapeutic option for SCID.
  • Ex vivo gene transfer into hematopoietic progenitor cells conferred a strong selective advantage.
  • Favorable kinetics of immune reconstitution were observed in treated infants.

Conclusions:

  • Retroviral gene therapy is a viable and effective treatment for certain SCID types, especially when matched HSCT is unavailable.
  • This gene-editing approach offers a promising alternative to haploidentical transplantation with improved outcomes.
  • Gene therapy facilitates successful immune reconstitution in infants with SCID.

More Related Videos

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview